Evaluation of teclistamab in BCMA-directed therapy exposed versus naive in relapsed/refractory multiple myeloma Meeting Abstract
| Authors: | Snyder, J.; Graf, K.; Davis, J. A.; McKenna, M.; Tiger, Y. K.; Laharwal, M. M.; Mewawalla, P.; Alkharabsheh, O.; Hashmi, H.; Shaikh, H.; Lochner, J.; Chang, D.; Atrash, S.; Habib, A.; Venkatesh, P.; Mahmoudjafari, Z.; Ahmed, N.; Mushtaq, M. U.; Abdallah, A.; Green, K. M.; Khan, A. M. |
| Abstract Title: | Evaluation of teclistamab in BCMA-directed therapy exposed versus naive in relapsed/refractory multiple myeloma |
| Meeting Title: | 66th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 144 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2024 Dec 7-10 |
| Meeting Location: | San Deigo, CA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2024-11-05 |
| Start Page: | 24117 |
| End Page: | 24118 |
| Language: | English |
| ACCESSION: | WOS:001412606200050 |
| DOI: | 10.1182/blood-2024-204158 |
| PROVIDER: | wos |
| Notes: | Source: Wos |
